Ozempic (semaglutide) injection

Ozempic side effects, Ozempic face, cost and how to get it prescribed online

Ozempic is a once-weekly semaglutide injection from Novo Nordisk. The FDA has approved it for adults with type 2 diabetes: to improve blood sugar alongside diet and exercise, and to lower cardiovascular and kidney risks in those who also have established cardiovascular disease or chronic kidney disease. Ozempic is not FDA-approved for weight loss.1

This page covers Ozempic side effects, what “Ozempic face” means, and what Ozempic costs with and without a coupon. A licensed FitRx provider can review your health history online and tell you whether Ozempic, Wegovy (the semaglutide brand approved for weight management) or a different plan makes sense.

  • Approved for type 2 diabetes, not for weight loss. A licensed provider decides what fits your health history
  • Your intake is read by a U.S.-licensed provider, typically within 1 to 2 business days
  • An insurance coordination team submits prior authorizations to commercial plans

Membership is $39 for the first month, then $135 a month, and medication is billed separately. Ozempic is not FDA-approved for weight loss. A provider decides whether any prescription is appropriate, and not everyone qualifies.

Ozempic (semaglutide) injection pen

What the Ozempic label shows about weight

In Ozempic’s label trial, adults with type 2 diabetes lost roughly 6% of their weight

Ozempic is FDA-approved for type 2 diabetes and is not approved for weight loss, so its trials were built around blood sugar. Weight was measured along the way, and every participant had type 2 diabetes.1

The trial behind the slider compared Ozempic 2 mg with Ozempic 1 mg for 40 weeks, with no placebo group. Average weight fell by 6.4 kg on 2 mg and by 5.6 kg on 1 mg, from an average starting weight of about 99 to 100 kg.1

The label reports kilograms, not percentages. We worked out the percentages ourselves: 5.6 kg and 6.4 kg divided by a starting weight of roughly 100 kg comes to about 5.6% and 6.4%, or roughly 6% at either dose. Treat both as approximate.

Two other trials on the label also reported weight in adults with type 2 diabetes:1

  • Ozempic on its own, 30 weeks: 3.8 kg on 0.5 mg and 4.7 kg on 1 mg, compared with 1.2 kg on placebo.
  • Ozempic compared with sitagliptin, 56 weeks: 4.2 kg on 0.5 mg and 5.5 kg on 1 mg, compared with 1.7 kg on sitagliptin.

For contrast, Wegovy is the semaglutide brand approved for weight management. In its STEP 1 trial, adults without diabetes took a higher dose, 2.4 mg, for 68 weeks and lost an average of 14.9% of their body weight, compared with 2.4% on placebo.2,3 Different dose, different people, longer trial: the two results cannot be swapped for each other.

All of these are group averages. Some people lost more and some lost less.

Estimate it for your starting weight

230 lb
Weekly dose

Average weight lost in the trial

about 15 lb

Approximate average change in body weight at 40 weeks in adults with type 2 diabetes, worked out from the kilogram results on the Ozempic label.1 Ozempic is not FDA-approved for weight loss. This illustrates trial averages and is not a prediction for you. Individual results vary.

Two routes to semaglutide through FitRx: Ozempic or a compounded version

Semaglutide is the active ingredient in Ozempic. When a FitRx provider decides semaglutide is appropriate for you, it can reach you in one of two forms. They are different products, and one is not a stand-in for the other.

FDA-approved for type 2 diabetes

Brand-name Ozempic

Made by Novo Nordisk and reviewed by the FDA for safety, effectiveness and quality as a type 2 diabetes treatment. It is not approved for weight loss. It comes as an injection pen.1

  • The product studied in the trials on the Ozempic label
  • FitRx’s insurance coordination team sends prior authorizations to commercial plans
  • You pay the pharmacy: your plan’s copay, or a cash price

Not FDA-approved

Compounded semaglutide

Made for an individual prescription by a state-licensed compounding pharmacy. Through FitRx the medication starts at $151 a month with a 3-month supply, in addition to membership. Shipping is included.

  • Arrives in a vial, and each dose is drawn up with a syringe
  • Not a generic of Ozempic or Wegovy, and not tested in the brand-name trials
  • Prescribed only if a provider decides it is appropriate for you

What “not FDA-approved” means. Before a compounded drug reaches a patient, the FDA has not checked it for safety, effectiveness or quality. The agency’s position is that compounded drugs should be used only by patients whose medical needs cannot be met by an FDA-approved drug.4 Whether that describes you is a judgment your provider makes with you.

If your goal is weight management

For weight management, the FDA-approved semaglutide brand is Wegovy, which has its own doses, trials and savings offers. Your provider will tell you which product, if any, matches your diagnosis. Our semaglutide page covers the brand-name and compounded options in more detail.

Is there an Ozempic pill?

Yes. Ozempic tablets are semaglutide taken by mouth once a day, and they are for type 2 diabetes only. The label starts at 1.5 mg a day for 30 days, then 4 mg, with 9 mg if more blood sugar control is needed. They are taken in the morning on an empty stomach with up to 4 ounces of water, at least 30 minutes before food, drink or other oral medicines.5 The rest of this page is about the weekly injection.

How getting Ozempic online works, from intake to follow-up

  1. Share your health history

    Complete an online intake about your conditions, medications, weight history and goals. Say whether you have type 2 diabetes, because that is what Ozempic is approved to treat.

  2. A provider reads it

    A U.S.-licensed physician or nurse practitioner reviews your intake, typically within 1 to 2 business days, and may come back with questions.

  3. Prescription and prior authorization

    If your provider decides Ozempic is appropriate, they write the prescription. When a commercial plan asks for a prior authorization, FitRx submits it. Most decisions arrive in 2 to 14 business days.

  4. Dose changes and check-ins

    Ozempic starts low and goes up in steps. Your provider handles each change, helps with side effects and can be messaged between monthly visits.

Ozempic’s label is written for adults with type 2 diabetes and sets no BMI cutoff.1 The labels for Wegovy and Zepbound, the weight management drugs, do: a BMI of 30 or higher, or 27 or higher with a weight-related condition.2,6 The BMI calculator gives you your number in a few seconds.

Your FitRx provider makes the final call on what to prescribe. Sometimes the answer is a different medication, or no medication at all.

Begin the online intake

What FitRx membership covers, and what you pay for separately

Ozempic’s label describes it as something used with diet and exercise, not in place of them.1 Membership is the clinical care and support around the medication.

Your provider

A licensed provider reviews your intake and makes every prescribing decision. You get unlimited secure messaging with them and a video or phone visit each month.

Coach and coordinator

A dedicated coach, plus a care coordinator you can message about logistics.

Insurance coordination

A team submits prior authorizations for brand-name GLP-1 medications. After a denial they can resubmit, up to three requests.

The price: $39 for the first month and $135 a month after that, billed monthly. HSA and FSA cards are accepted, and quarterly, semi-annual and annual plans are discounted. You can cancel at any time in the patient portal. A membership cannot be paused, and a prior authorization only stays in place while the membership is active.

Paid separately: the medication. Brand-name Ozempic is bought at a pharmacy, for your plan’s copay or a cash price. FitRx does not sell it, and its price is set by your insurer, the pharmacy and Novo Nordisk.

Government insurance: FitRx does not work with Medicare, Medicaid or TRICARE.

Ozempic side effects: what is common and what is serious

The most common Ozempic side effects are stomach and gut problems. The table shows how often each was reported in placebo-controlled trials of the 0.5 mg and 1 mg doses in adults with type 2 diabetes.1

Side effectPlaceboOzempic 0.5 mgOzempic 1 mg
Nausea6.1%15.8%20.3%
Vomiting2.3%5.0%9.2%
Diarrhea1.9%8.5%8.8%
Abdominal pain4.6%7.3%5.7%
Constipation1.5%5.0%3.1%
Any stomach or gut reaction15.3%32.7%36.4%

Share of adults reporting each reaction (262 people on placebo, 260 on 0.5 mg, 261 on 1 mg), from the Ozempic prescribing information.1

When stomach side effects tend to show up

According to the label, most of the nausea, vomiting and diarrhea happened while doses were being raised. A small share of people stopped treatment because of stomach or gut reactions: 3.1% on 0.5 mg and 3.8% on 1 mg, compared with 0.4% on placebo. In the trial comparing the two highest doses, these reactions were reported by 34% of people on 2 mg and 30.8% on 1 mg.1

How Ozempic dosing works

Ozempic is injected under the skin of the abdomen, thigh or upper arm once a week, on the same day each week, with or without meals. The label starts at 0.25 mg for 4 weeks, then moves to 0.5 mg. If more blood sugar control is needed after at least 4 weeks, the dose can go up to 1 mg, and later to 2 mg, the maximum.1 Your provider sets your dose. The Ozempic dosage guide has the full chart, the pen that delivers each dose, and what to do about a missed dose.

Living with the common ones

  • Keep drinking. The medication guide says it is important to drink fluids to lower the chance of dehydration when you have nausea, vomiting or diarrhea. Fluid loss is how the kidney injury on the label happens.1
  • Speak up about a rough dose. If a step up is hard on your stomach, tell your provider so they can decide what to do next.
  • List your other medicines. Ozempic slows stomach emptying, which may change how medicines taken by mouth are absorbed.

Is “Ozempic face” one of the side effects?

No. It is not among the adverse reactions on the Ozempic label. The next section explains what it is.

Serious risks and their warning signs

These are the warnings on the Ozempic label:1

  • Thyroid C-cell tumors. Ozempic has a boxed warning because semaglutide caused these tumors in rodents. Do not use it with a personal or family history of medullary thyroid carcinoma, or with MEN 2. Report a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
  • Pancreatitis. Severe pain in the stomach area that will not go away, with or without vomiting, sometimes felt in the back.
  • Diabetic retinopathy complications. Report any change in your vision.
  • Low blood sugar when taken with insulin or an insulin secretagogue such as a sulfonylurea.
  • Kidney injury caused by fluid loss.
  • Severe stomach and gut reactions. Ozempic is not recommended for people with severe gastroparesis.
  • Serious allergic reactions, including anaphylaxis and angioedema.
  • Gallbladder problems: pain in the upper stomach, fever, yellowing of the skin or eyes, or clay-colored stools.
  • Aspiration during anesthesia. Tell the team doing any procedure with general anesthesia or deep sedation that you take Ozempic.

The fuller summary is in the important safety information below. Our guide to GLP-1 side effects looks across the whole drug class.

Ozempic face: what the phrase means and where the change comes from

“Ozempic face” is an informal name, not a medical diagnosis. People use it to describe how a face can look after someone has lost a substantial amount of weight: less volume, and less fullness than before.

The name points at the wrong cause. The change follows weight loss itself. It is not a side effect listed on the Ozempic label, and it is not specific to Ozempic or to semaglutide.1

QuestionWhat can honestly be said
Is it on the Ozempic label?No. The label’s most common reactions are nausea, vomiting, diarrhea, abdominal pain and constipation.
Is it unique to Ozempic or semaglutide?No. It follows weight loss, whatever led to that weight loss.
Is there a statistic for how often it happens?Not on the label, so this page does not quote one.
Can it be prevented?Nobody can promise that.

Why weight loss can show in the face

Your face carries some fat under the skin, as the rest of your body does. When you lose a substantial amount of weight, some of that fullness can go too, and your face can look leaner than it used to. How noticeable that is differs from person to person.

So the change is tied to the weight a person loses, not to the name on the pen. Ozempic itself is not approved for weight loss, and the trial results above show the average weight change in its diabetes trials.

What to bring up with your provider

  • The pace of your weight loss. If weight is coming off faster than you expected, or faster than you are comfortable with, say so. Your provider decides whether and when a dose changes.
  • Whether you are eating enough protein. Protein is easy to under-eat when you are eating less overall. The protein calculator gives you a daily range to discuss. Protein is about nutrition and muscle. It is not a proven way to change how your face looks.
  • Cosmetic questions. If the look of your face bothers you, a dermatologist is the right person to ask.
  • Swelling is different. Swelling of the face, lips or throat is not “Ozempic face”. It can be a sign of angioedema, one of the serious allergic reactions on the label, and it needs medical help right away.

We do not give a figure for how common “Ozempic face” is or how long it lasts, because the Ozempic label has no entry for it. If the comments are coming from colleagues, our guide to Ozempic weight loss conversations at work covers what to say and what you can keep to yourself.

Ozempic coupon and cost: who the $25 offer is for

The Ozempic coupon is Novo Nordisk’s own savings offer, and it helps one group: people whose commercial insurance already covers Ozempic. The figures below are Novo Nordisk’s published terms as of November 18, 2026.7,8

Your situationWhat you could pay for OzempicLimits to know
Commercial insurance that covers OzempicAs little as $25 a monthThe savings offer takes off at most $100 a month, for up to 48 months.
Paying cash (self-pay), new patient$199 a month for the first 2 fills of 0.25 mg or 0.5 mgIntroductory price, through December 31, 2026.
Paying cash (self-pay), ongoing$349 a month for 0.25 mg, 0.5 mg or 1 mg; $499 a month for 2 mgThrough NovoCare Pharmacy or participating pharmacies. One month is one pen.
Medicare Part DDepends on your planNot eligible for the $25 offer. Most Part D plans cover Ozempic for diabetes.
Another government programDepends on the programExcluded from the savings offer.
List price, nothing applied$1,027.51 per penThe same for every strength.

Sources: Novo Nordisk’s Ozempic savings and NovoCare pages.7,8 Novo Nordisk can change these prices and terms, so check them with the company or your pharmacy before you fill.

How the $25 Ozempic savings offer works

The offer lowers what your insurance leaves you to pay. It does not replace insurance. The most it takes off is $100 a month, and that cap is the part people miss. As an example of the arithmetic: if your plan’s share for a month of Ozempic is $90, the offer can bring it down to $25. If your plan leaves you with $200, the offer takes off $100 and you pay $100.

Ozempic cost without insurance

The self-pay prices in the table are for the pen. For Ozempic tablets, Novo Nordisk says self-pay pricing varies by dose and lists tiers of $149, $199 and $299.8 Discount cards from other companies work differently: a coupon price is a cash price, used in place of insurance, and it cannot be combined with the $25 offer.

Ozempic, weight loss and insurance

Ozempic is not FDA-approved for weight loss. Its approved uses are all in adults with type 2 diabetes, and each plan decides which uses it will pay for. If weight management is your goal and you do not have diabetes, the semaglutide brand with that approval is Wegovy.

Many plans ask for a prior authorization before they cover a brand-name GLP-1. FitRx’s insurance coordination team submits these for members with commercial insurance. The plan decides, and approval is never guaranteed. Our GLP-1 insurance coverage page explains the process.

Ozempic and Medicare

Medicare Part D patients cannot use the $25 offer. Novo Nordisk notes that most Part D plans cover Ozempic for diabetes and that the cost varies by plan.8 Ozempic is also not one of the drugs covered by the Medicare GLP-1 Bridge, the short-term federal program for weight management drugs, and people with type 2 diabetes are not eligible for that program.9,10 FitRx does not work with government insurance. Your Part D plan or 1-800-MEDICARE can tell you what you would pay.

The total with FitRx

Two bills make up the monthly total: FitRx membership ($39 for the first month, then $135 a month) and the medication, which is paid for separately.

  • Brand-name Ozempic with covered commercial insurance: as little as $25 a month at the pharmacy, within the limits above.
  • Brand-name Ozempic without coverage: the self-pay price for your dose.
  • Compounded semaglutide, if your provider decides it is appropriate: from $151 a month with a 3-month supply. It is not FDA-approved, is not reviewed by the FDA for safety, effectiveness or quality, and is not a generic of Ozempic.

Be wary of prices that look too good

The FDA says counterfeit Ozempic is illegal, and its red flags for telehealth sellers include deep discounts that seem too good to be true. Buy only from a state-licensed pharmacy.4

NovoCare Pharmacy can ship your Ozempic. It cannot prescribe it.

NovoCare Pharmacy is Novo Nordisk’s own pharmacy service. It is one of the places where the self-pay prices in the cost section apply, and it ships Ozempic directly to you.8

As of November 18, 2026, those prices are $349 a month for 0.25 mg, 0.5 mg or 1 mg and $499 a month for 2 mg, with a $199 introductory price for a new patient’s first 2 fills of 0.25 mg or 0.5 mg through December 31, 2026. One month is one pen.8 Confirm the current price before you order.

What NovoCare does not do is decide whether Ozempic is right for you. It is a pharmacy service, so everything starts with a prescription from a licensed clinician.

QuestionFitRxNovoCare Pharmacy
What is it?Online care from licensed providers, through a membershipNovo Nordisk’s pharmacy service
Does it evaluate you and prescribe?Yes, when a provider decides medication is appropriateNo. It fills prescriptions written by someone else
Does it sell Ozempic?No. You pay a pharmacy for brand-name medicationYes, at Novo Nordisk’s self-pay prices
What do you pay it?$39 the first month, then $135 a monthThe price of the medication

So the two can fit together. If you expect to pay cash for brand-name Ozempic, tell your FitRx provider during intake and ask whether your prescription can be sent to NovoCare Pharmacy. You would pay the pharmacy for the medication and FitRx for the care around it.

How Ozempic compares with Wegovy, Mounjaro and Zepbound

Ozempic and Mounjaro are approved for type 2 diabetes and are not approved for weight loss. Wegovy and Zepbound are approved for weight management.

MedicationActive ingredientFDA-approved forAverage weight change in a label trial
OzempicSemaglutideType 2 diabetes. Not approved for weight loss.Roughly 6% at 40 weeks (1 mg or 2 mg, adults with type 2 diabetes)1
WegovySemaglutideWeight management; cardiovascular risk reduction; MASH14.9% at 68 weeks (2.4 mg, adults without diabetes)2
MounjaroTirzepatideType 2 diabetes. Not approved for weight loss.Roughly 12% at 40 weeks (15 mg, adults with type 2 diabetes)11
ZepboundTirzepatideWeight management; obstructive sleep apnea with obesity20.9% at 72 weeks (15 mg, adults without diabetes)6

The Ozempic and Mounjaro figures are approximate, worked out from kilogram results. Each trial had its own participants, doses and length, so do not read one row directly against another.

Ozempic and Wegovy

Both are semaglutide from Novo Nordisk. The differences are the approved use and the dose: Ozempic’s maintenance doses are 0.5 mg, 1 mg or 2 mg a week, and Wegovy’s recommended adult maintenance dose is 2.4 mg a week.1,2 Diabetes also changes the picture. When Wegovy was studied in adults with type 2 diabetes, average weight loss was 9.6%, compared with 3.4% on placebo.2

Ozempic and Mounjaro

SURPASS-2 compared tirzepatide, the ingredient in Mounjaro, with semaglutide 1 mg for 40 weeks in adults with type 2 diabetes taking metformin. Average weight change was 7.6 kg, 9.3 kg and 11.2 kg on Mounjaro 5 mg, 10 mg and 15 mg, and 5.7 kg on semaglutide 1 mg.11,12 The trial did not test Ozempic’s 2 mg maximum. Our Mounjaro vs. Ozempic guide sets out dosing, side effects and cost side by side.

What Ozempic has that is not about weight

In SUSTAIN 6, which ran for 2.1 years, major cardiovascular events happened in 6.6% of people on Ozempic and 8.9% on placebo. In FLOW, a trial of the 1 mg dose in adults with type 2 diabetes and chronic kidney disease, a combined kidney outcome occurred in 18.7% of people on Ozempic and 23.2% on placebo.1,13

Trial averages are one input. Your diagnosis, your coverage and how you tolerate a medication matter as much. Our tirzepatide page covers the other ingredient.

A person messaging their FitRx care team in the patient portal on a phone

The FitRx care team

A licensed provider makes every Ozempic decision

Whether Ozempic suits you depends on your diagnosis, your other medications and your medical history, and an online form cannot weigh those. At FitRx a U.S.-licensed physician or nurse practitioner reads your intake and decides what to prescribe, if anything. If Ozempic is not the right choice, they will tell you so.

  • U.S.-licensed providers review every intake and make every prescribing decision
  • Unlimited secure messaging, plus monthly video or phone visits
  • A care coordinator and a coach alongside your provider
  • An insurance coordination team for brand-name GLP-1 prior authorizations

This page was written and reviewed by the FitRx care team and last updated November 18, 2026. It is general information, not personal medical advice.

Ozempic FAQs

Is Ozempic approved for weight loss?

No. Ozempic is FDA-approved for adults with type 2 diabetes: to improve blood sugar with diet and exercise, and to reduce cardiovascular and kidney risks in those who also have established cardiovascular disease or chronic kidney disease. Wegovy is the semaglutide brand approved for weight management.

What are the most common Ozempic side effects?

Nausea, vomiting, diarrhea, abdominal pain and constipation. In placebo-controlled trials, nausea was reported by 15.8% of adults on 0.5 mg and 20.3% on 1 mg, compared with 6.1% on placebo.

How long do Ozempic side effects last?

The label does not give a number of days or weeks. It says most nausea, vomiting and diarrhea in the trials happened while doses were being increased. If symptoms are severe or keep you from drinking fluids, contact your provider.

What is Ozempic face?

It is an informal name for how the face can look after a person loses a substantial amount of weight: less volume and less fullness. It is not a medical diagnosis, and it follows from weight loss itself.

Is Ozempic face a side effect of Ozempic?

No. It is not a side effect listed on the Ozempic label, and it is not specific to Ozempic or to semaglutide. Swelling of the face, lips or throat is a different matter: it can be a sign of angioedema, a serious allergic reaction on the label, and it needs medical help right away.

Can Ozempic face be prevented?

Nobody can promise that, and the Ozempic label has no data on it. Because it follows weight loss, reasonable things to discuss with your provider are the pace of your weight loss and whether you are eating enough protein. For cosmetic questions, ask a dermatologist.

How much weight do people lose on Ozempic?

Ozempic is not approved for weight loss, and its trials were in adults with type 2 diabetes. In the 40-week trial on its label, average weight fell by 6.4 kg on 2 mg and 5.6 kg on 1 mg from a starting weight of about 99 to 100 kg, roughly 6% at either dose. Individual results vary.

How much does Ozempic cost without insurance?

As of November 18, 2026, Novo Nordisk's self-pay price is $199 a month for a new patient's first 2 fills of 0.25 mg or 0.5 mg (through December 31, 2026), then $349 a month for 0.25 mg, 0.5 mg or 1 mg, and $499 a month for 2 mg. The list price is $1,027.51 per pen. Confirm current prices before you fill.

Is there an Ozempic coupon?

Yes. As of November 18, 2026, Novo Nordisk's savings offer lets people with commercial insurance that covers Ozempic pay as little as $25 a month, with a maximum saving of $100 a month, for up to 48 months. People covered by government programs are excluded. Terms can change, so confirm them with Novo Nordisk.

Can I use the Ozempic savings offer with Medicare?

No. Medicare Part D patients are not eligible for the $25 offer. Novo Nordisk notes that most Part D plans cover Ozempic for diabetes and that the cost varies by plan. FitRx does not work with government insurance.

Can I get Ozempic prescribed online?

Yes, when a licensed provider judges that it is appropriate. At FitRx the process starts with an online intake, which a U.S.-licensed provider reads, typically within 1 to 2 business days. Because Ozempic is approved for type 2 diabetes, the provider may suggest a different medication, or none.

Can I get Ozempic through NovoCare?

Once you have a prescription, yes. NovoCare Pharmacy is Novo Nordisk's pharmacy service, and it ships Ozempic directly to you. It does not evaluate patients or write prescriptions, so a licensed clinician has to prescribe first.

Is Ozempic the same as Wegovy?

They contain the same active ingredient, semaglutide, and both are made by Novo Nordisk. Ozempic is approved for type 2 diabetes, with maintenance doses of 0.5 mg, 1 mg or 2 mg a week. Wegovy is approved for weight management, with a recommended adult maintenance dose of 2.4 mg a week.

Is compounded semaglutide the same as Ozempic?

No. They are different products. Compounded semaglutide is not FDA-approved, which means the FDA has not checked it for safety, effectiveness or quality. It is also not a generic of Ozempic or Wegovy, and it was never part of the brand-name trials. Whether a compounded medication suits a given patient is a licensed provider's decision.

What is the highest dose of Ozempic?

The maximum is 2 mg once a week. The label starts at 0.25 mg for 4 weeks, moves to 0.5 mg, and allows increases to 1 mg and then 2 mg, each after at least 4 weeks, if more blood sugar control is needed. Your provider decides your dose.

Does FitRx work with insurance for Ozempic?

FitRx's insurance coordination team submits prior authorizations for brand-name Ozempic to commercial plans, and most decisions come back in 2 to 14 business days. The membership fee is separate from the cost of medication. FitRx does not work with government insurance such as Medicare, Medicaid or TRICARE.

Important safety information for Ozempic

Boxed warning: risk of thyroid C-cell tumors. Semaglutide caused thyroid C-cell tumors in rodents. Do not use Ozempic if you have a personal or family history of medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider about a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.

What Ozempic is for. Ozempic (semaglutide) injection is a prescription medicine for adults with type 2 diabetes. It is used with diet and exercise to improve blood sugar; to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease; and to reduce the risk of sustained decline in kidney function, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. Ozempic is not FDA-approved for weight loss.1

Do not use Ozempic if you have a personal or family history of MTC, if you have MEN 2, or if you have had a serious allergic reaction to semaglutide or any ingredient in Ozempic.

Warnings and precautions. Ozempic can cause:

  • Inflammation of the pancreas (pancreatitis). Get medical help for severe pain in the stomach area that will not go away, with or without vomiting.
  • Complications of diabetic retinopathy. People with a history of diabetic retinopathy should be monitored.
  • Low blood sugar, when used with insulin or an insulin secretagogue such as a sulfonylurea.
  • Kidney injury, when vomiting or diarrhea leads to fluid loss. Drink fluids to lower the chance of dehydration.
  • Severe stomach and intestinal reactions. Ozempic is not recommended for people with severe gastroparesis.
  • Serious allergic reactions, including anaphylaxis and angioedema.
  • Gallbladder disease, including gallstones and inflammation of the gallbladder. Signs include pain in the upper stomach, fever, yellowing of the skin or eyes, and clay-colored stools.
  • Food or liquid getting into the lungs during general anesthesia or deep sedation.

Never share an Ozempic pen with another person.

Most common side effects (5% or more of people): nausea, vomiting, diarrhea, abdominal pain and constipation.

Pregnancy. Stop Ozempic at least 2 months before a planned pregnancy, because semaglutide stays in the body for a long time.

Other medicines. Ozempic slows stomach emptying and may change how medicines taken by mouth are absorbed. Give your provider a full list of your medicines.

These points are a short version of the label, not a substitute for the full prescribing information or for talking with your provider.1 Side effects can be reported to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

A note on compounded semaglutide. The safety information above comes from the Ozempic label and applies to Ozempic. Compounded semaglutide is not FDA-approved: the FDA has not checked it for safety, effectiveness or quality, it is not a generic of Ozempic or Wegovy, and it was not part of the brand-name clinical trials.4

See whether Ozempic belongs in your treatment plan

Complete the online intake. A licensed provider reads it and tells you what they recommend, whether that is Ozempic, another medication or neither.

Get started

FitRx membership costs $39 in month one and $135 a month from then on. Medication is a separate charge. Not everyone qualifies.

References (13)
  1. Ozempic (semaglutide) injection. Prescribing information. Novo Nordisk; revised May 2026. https://www.novo-pi.com/ozempic.pdf
  2. Wegovy (semaglutide) injection and tablets. Prescribing information. Novo Nordisk; revised June 2026. https://www.novo-pi.com/wegovy.pdf
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  4. U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. Content current as of October 1, 2026. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  5. Rybelsus and Ozempic (semaglutide) tablets. Prescribing information. Novo Nordisk; revised January 2026. https://www.novo-pi.com/ozempictablets.pdf
  6. Zepbound (tirzepatide) injection. Prescribing information. Eli Lilly and Company; revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
  7. Novo Nordisk. NovoCare: Ozempic savings offer and list price. https://www.novocare.com/diabetes/products/ozempic/savings-offer.html
  8. Novo Nordisk. Save on Ozempic: savings offer, self-pay prices and Medicare information. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
  9. Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
  10. Medicare.gov. Weight loss drugs and the Medicare GLP-1 Bridge. https://www.medicare.gov/coverage/weight-loss-drugs
  11. Mounjaro (tirzepatide) injection. Prescribing information. Eli Lilly and Company; revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
  12. Frias JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/
  13. Perkovic V, Tuttle KR, Rossing P, et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes (FLOW). N Engl J Med. 2024;391(2):109-121. https://pubmed.ncbi.nlm.nih.gov/38785209/

Sources were opened and checked on November 18, 2026. Prices, savings programs and labels change; confirm current terms with the manufacturer, your pharmacy or your provider.